Am J Perinatol 2022; 39(03): 238-242
DOI: 10.1055/s-0041-1739358
SMFM Fellowship Series Article

Pregnancy Outcomes among Women with Class III Obesity with Pre-diabetic Early Hemoglobin A1C

1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
,
1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
,
Tressa Ellett
1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
,
Anne Siegel
1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
,
Anna E. Denoble
1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
,
Sarah K. Dotters-Katz
1   Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina
› Author Affiliations

Abstract

Objective We aimed to assess the risk of developing gestational diabetes mellitus (GDM) in women with a normal A1C (<5.7) compared with those with an A1C in the pre-diabetic range (5.7–6.4).

Study Design This study comprises of a retrospective cohort of non-anomalous singleton pregnancies with maternal body mass index (BMI) ≥40 at a single institution from 2013 to 2017. Pregnancies with multiple gestation, late entry to care, type 1 or 2 diabetes, and missing diabetes-screening information were excluded. The primary outcome was development of GDM. Secondary outcomes included fetal growth restriction, macrosomia, gestational age at delivery, large for gestational age, delivery BMI at delivery, total weight gain in pregnancy, induction of labor, shoulder dystocia, and cesarean delivery. Bivariate statistics were used to compare demographics, pregnancy complications, and delivery characteristics of women who had an early A1C < 5.7 and A1C 5.7 to 6.4. Multivariable analyses were used to estimate the odds of the primary outcome.

Results Eighty women (68%) had an early A1C <5.7 and 38 (32%) had a A1C 5.7 to 6.4. Women in the lower A1C group were less likely to be Black (45 vs. 74%, p = 0.01). No differences in other baseline demographics were observed. The median A1C was 5.3 for women with A1C < 5.7 and 5.8 for women with A1C 5.7 to 6.4 (p < 0.001). GDM was significantly more common in women with A1C 5.7 to 6.4 (3.8 vs. 24%, p = 0.002). Women with pre-diabetic range A1C had an odd ratio of 11.1 (95% CI 2.49–48.8) for GDM compared with women with a normal A1C.

Conclusion Women with class III obesity and a pre-diabetic range A1C are at an increased risk for gestational diabetes when compared with those with a normal A1C in early pregnancy.

Key Points

  • One in 3 women with class III obesity had a pre-diabetic range early A1C.

  • Class III obese women who have a pre-diabetic A1C have a higher risk of gestational diabetes.

  • In this high-risk population, early A1C results in the pre-diabetic range are associated with higher rates of gestational diabetes.

Note

This abstract was presented as a poster at the Society of Maternal Fetal Medicine's 40th Annual Pregnancy from February 5 to 8, 2019 in Grapevine, TX.




Publication History

Received: 23 September 2020

Accepted: 06 October 2021

Article published online:
10 December 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Moyer VA. U.S. Preventive Services Task Force. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 160 (06) 414-420
  • 2 Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009; 373 (9677): 1773-1779
  • 3 ACOG Practice Bulletin No. ACOG Practice Bulletin No. 190 Summary: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) 406-408
  • 4 Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med 2009; 14 (02) 119-124
  • 5 Metzger BE, Lowe LP, Dyer AR. et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358 (19) 1991-2002
  • 6 Metzger BE, Persson B, Lowe LP. et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics 2010; 126 (06) e1545-e1552
  • 7 Committee on Practice B-O. ACOG Practice Bulletin No. ACOG Practice Bulletin No. 190: gestational diabetes mellitus. Obstet Gynecol 2018; 131 (02) e49-e64
  • 8 Rajput R, Yogesh Yadav, Rajput M, Nanda S. Utility of HbA1c for diagnosis of gestational diabetes mellitus. Diabetes Res Clin Pract 2012; 98 (01) 104-107
  • 9 Agarwal MM, Dhatt GS, Punnose J, Koster G. Gestational diabetes: a reappraisal of HBA1c as a screening test. Acta Obstet Gynecol Scand 2005; 84 (12) 1159-1163
  • 10 American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 (Suppl. 01) S62-S69
  • 11 Hinkle SN, Tsai MY, Rawal S, Albert PS, Zhang C. HbA1c measured in the first trimester of pregnancy and the association with gestational diabetes. Sci Rep 2018; 8 (01) 12249
  • 12 Osmundson SS, Zhao BS, Kunz L. et al. First trimester hemoglobin A1c prediction of gestational diabetes. Am J Perinatol 2016; 33 (10) 977-982
  • 13 Sovio U, Murphy HR, Smith GC. Accelerated fetal growth prior to diagnosis of gestational diabetes mellitus: a prospective cohort study of nulliparous women. Diabetes Care 2016; 39 (06) 982-987